Upcoming Webinars

Bone Club Series

Join SIO for an intermediate-level (200) musculoskeletal (MSK) three-part webinar series. Part one will focus on the interventional treatment of malignant and metastatic bone lesions in both the axial and appendicular skeleton, covering techniques like ablation, cementation, and embolization. Part two will focus on the finer details of patient evaluation and procedural techniques for benign bone lesions, demonstrating bone grafting for UBC/ABC. Part three addresses the general guidelines and physiology for the management of oncologic pain using cryoneurolysis, techniques for managing chest wall masses and ablative options for management of aggressive pelvic disease tumors.

To get the most out of the series, we recommend registering for all three sessions.

Part 1: How I Do It—From Imaging Workup to Intervention: Metastatic/Malignant Bone Lesions

Wednesday, 24 September 2025 | 7 – 8:30 p.m. ET

Faculty

Moderator

Gina Landinez, MD

Baptist Health - Miami Cardiac and Vascular Institute (MCVI)

Faculty Panel

Jason Levy MD, FSIR

Northside Radiology Associates

Marwan Moussa, MD

Beth Israel Deaconess Medical Center

Brandon Key, MD

Froedtert & Medical College of Wisconsin

Register Now

Part 2: How I Do It—From Imaging Workup to Intervention: Benign MSK Lesions

Wednesday, 8 October 2025 | 7 – 8:30 p.m. ET

Faculty

Moderator

Thedore Vander Velde, MD

Mallinckrodt Institute of Radiology

Faculty Panel

James Murakami, MD, MS

Nationwide Children's Hospital

Shankar Rajeswaran, MD

Northwestern University

Eric Monroe, MD

University of Wisconsin

Register Now

Part 3: How I Do It—From Imaging Workup to Intervention: Cryoneurolysis for Pain

Wednesday, 11 November 2025 | 7 – 8:30 p.m. ET

Faculty

Moderator

Sirish Kishore, MD

Stanford University

Faculty Panel

Junjian Huang, MD

Emory Healthcare

Shantanu Warhadpande MD

University of Michigan

John David Prologo, MD

Emory Healthcare

Register Now

Bone Club is supported by:

Advancing Ablation: Clinical Perspectives on Emprint™ and OsteoCool™

Thursday, 25 September 2025 | 5:30 – 6:30 p.m. ET

This panel discussion will feature leading interventional radiologists sharing their clinical experience with microwave and radiofrequency ablation technologies — specifically Emprint™ Microwave Ablation and OsteoCool™ RF Ablation. The session will highlight treatment strategies, case insights, and procedural considerations across soft tissue and bone tumor applications.

Faculty

Moderator

Jack Jennings, MD, PhD, FSIR

Washington University School of Medicine

Faculty Panel

Jawad Hussain, MD, MS

Commonwealth Interventional Radiology

Nicole Keefe, MD

University of North Carolina

Rahul Sheth, MD, FSIR

MD Anderson Cancer Center

Register Now

This webinar is sponsored by

Special Edition RMSS Journal Club: IO Means Business: Money, Models, and Market Shifts

Monday, 29 September 2025 | 6 p.m. ET

Join us for a dynamic discussion on the evolving financial landscape of Interventional Oncology. This journal club will explore how business models, reimbursement trends, and market dynamics are reshaping IR practice. Through three key articles, we’ll examine the ethical balance between profitability and patient care, and empower future IRs to navigate the economic forces driving our specialty.

Faculty

Moderator

Jacy Lundberg, MD

University of Pennsylvania

Faculty

Riad Salem, MD

Northwestern Medicine

Mary Costantino, MD

Advanced Vascular Centers

Register Now

This webinar is sponsored by:

HCC Webinar Series

Join SIO for a three-part webinar series on hepatocellular carcinoma (HCC) this fall. Part one will cover advances in treatment with a shift toward combination therapies and sequencing strategies to optimize patient outcomes. Part two will explore the role of immunotherapy in HCC, including combinations with locoregional therapies, mechanisms of resistance, biomarker predictions and other therapeutic targets. Part three will highlight ongoing critical trials of combination locoregional therapy and immunotherapy in the liver.

To get the most out of the series, we recommend registering for all three sessions.

Part 1: Advancing HCC Treatment: Sequencing Strategies and Managing Combination Therapies

Tuesday, 30 September 2025 | 7 – 8 p.m. ET

Faculty

Moderator

Julius Chapiro, MD, PhD

Yale University

Faculty Panel

Richard Finn, MD

University of California Los Angeles

Nicholas Fidelman, MD

University of California San Francisco

Register Now

Part 2: Integrating Immunotherapy with Locoregional Therapies in HCC: Mechanisms, Biomarkers, and Resistance

Wednesday, 22 October 2025 | 7 – 8 p.m. ET

Faculty

Moderator

Julius Chapiro, MD, PhD

Yale University

Faculty Panel

Terrance Gade, MD, PhD

University of Pennsylvania

Sarah Manes

Global Liver Institute

Anjana Pillai, MD

University of Chicago

Michael Soulen, MD

University of Pennsylvania

Register Now

Part 3: Ongoing Critical Trials of Combination Locoregional Therapy and Immunotherapy in the Liver

Tuesday, 4 November 2025 | 7 – 8:30 p.m. ET

This webinar is sponsored by:

Faculty

Moderator

Zach Berman, MD

UC San Diego

Faculty Panel

Adam Burgoyne, MD, PhD

UC San Diego

Kirema Garcia-Reyes, MD

Mount Sinai

Christopher Malone, MD

Washington University

Register Now

This webinar series is sponsored by:

Targeting Tumors from Within: Intratumoral Therapies and Team-Based Care in Metastatic Melanoma

Postponed: Stay tuned for more details

Join us for an engaging webinar titled “Targeting Tumors from Within: Intratumoral Therapies and Team-Based Care in Metastatic Melanoma,” sponsored by Replimune and Johnson & Johnson. This session will explore the evolving treatment landscape for advanced melanoma, with a particular focus on patients who have progressed on PD-1 inhibitors. Attendees will gain valuable insights into second-line treatment strategies, including the role of oncolytic immunotherapies.

Faculty

Rahul Sheth, MD, FSIR

MD Anderson Cancer Center

Michael Wong, MD, PhD, FRCPC

Roswell Park Comprehensive Cancer Center

This webinar is sponsored by: